JNPR vs PYXS · P/E 38, $13.36B cap vs rev $2.8M
Juniper Networks Inc (JNPR) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
JNPR does not have a complete income-statement cache yet.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
JNPR currently screens at market cap $13.36B and trailing P/E 38.0. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the JNPR and PYXS stock pages for the full models.
Not investment advice.